البلد: أيرلندا
اللغة: الإنجليزية
المصدر: HPRA (Health Products Regulatory Authority)
Cetylpyridinium chloride; Eucalyptus oil; Menthol
Sanofi-Aventis Ireland Limited T/A SANOFI
R02AA; R02AA06
Cetylpyridinium chloride; Eucalyptus oil; Menthol
1.4 mg/5mg/3 milligram(s)
Lozenge
Product not subject to medical prescription
Antiseptics; cetylpyridinium
Not marketed
1998-04-19
Reference: 17831 1.3.1.3 - Leaflet Text - PIL - 1.4mg, 5.0mg, 3.0mg - 2014-09-10 - 000000 - Plus - COA - 540/177/1 0.2 PATIENT INFORMATION LEAFLET Lozenge Cetylpyridinium Chloride 1.4mg, Menthol 5mg and Eucalyptus Oil 3mg READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU STARTS TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist or nurse has told you. - Keep this leaflet. You may need to read it again. - Ask your pharmacist if you need more information or advice. - If you get any side effects, talk to your doctor or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. - You must talk to a doctor if you do not feel better or if you feel worse after three days. WHAT IS IN THIS LEAFLET 1. What Merocets Plus are and what they are used for 2. What you need to know before you take Merocets Plus 3. How to take Merocets Plus 4. Possible side effects 5. How to store Merocets Plus 6. Contents of the pack and other information 1. WHAT MEROCETS PLUS ARE AND WHAT THEY ARE USED FOR Merocets Plus are lozenges that are used to provide relief from SORE THROATS and BLOCKED NOSES. Merocets Plus contain cetylpyridinium chloride, menthol and eucalyptus oil. Cetylypyridinium chloride has antiseptic properties and menthol and eucalyptus help relieve nasal congestion. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE THIS MEDICINE DO NOT TAKE MEROCETS PLUS • If you are allergic to Cetylpyridinium Chloride, Menthol and Eucalyptus Oil or any of the other ingredients of this medicine listed in section 6. See 'Contents of the pack and other information' for the full list of ingredients. • If you have been told by your doctor that you have intolerance to some sugars, contact your doctor before taking this medicinal product TALK TO YOUR DOCTOR OR PHARMACIST • If you develop a fever or your sore throat worsens or persists for more than three days consult your doctor. Reference: 17831 1.3 اقرأ الوثيقة كاملة
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Merocets Plus Lozenges Cetylpyridinium chloride 1.4 mg Menthol 5.0 mg Eucalyptus oil 3.0 mg 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each lozenge contains Cetylpyridinium chloride 1.4mg Menthol 5.0mg Eucalyptus oil 3.0mg Excipient with known effect: Sucrose 1.13g per lozenge and glucose 1.31 g per lozenge. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Lozenges. Off-white, round, plain lozenge with a menthol/eucalyptus flavour. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Symptomatic relief of sore throats and nasal congestion. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Oral ADULTS AND CHILDREN 6 YEARS OR OVER: One lozenge every 3 hours. Allow the lozenge to dissolve slowly in the mouth. CHILDREN UNDER 6 YEARS: not recommended 4.3 CONTRAINDICATIONS Hypersensitivity to any of the active ingredients or excipients. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Consult your doctor in case of severe irritation of your throat with high fever or if symptoms persist for more than 3 days. Exercise caution if you suffer from diabetes mellitus. Merocets Plus contains sucrose and glucose. Patients with rare hereditary problems of fructose intolerance, glucose- galactose malabsorption or sucrose-isomaltase insufficiency should not take this medicine. H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _2_ _1_ _/_ _0_ _9_ _/_ _2_ _0_ _1_ _7_ _C_ _R_ _N_ _ _ _2_ _1_ _9_ _3_ _8_ _4_ _5_ _p_ _a_ _g_ _e_ _ اقرأ الوثيقة كاملة